Prevention

Italy


Italian Association for the Study of the Liver (AISF)

Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease

Click here

United Kingdom


National Institute for Health and Care Excellence (NICE)

Liver Disease Quality Standards: covers identifying, assessing and managing chronic liver disease, and describes priority areas for improvement

Click here

 

British Medical Journal

Hepatic steatosis best practice guidelines from the BMJ. Requires journal access.

Click here

Screening and diagnosis

Worldwide


World Gastroenterology Organisation

Practice guidelines from the WGO for diagnosis and treatment of NAFLD & NASH

Click here

Regional


American Association for the Study of Liver Diseases (AASLD)

The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases

Click here

 

ACG clinical guidelines on the evaluation of abnormal liver chemistries

Click here

 

EASL–EASO–EASD

EASL– European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Click here

Italy


Italian Association for the Study of the Liver (AISF)

Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease

Click here

United Kingdom


National Institute for Health and Care Excellence (NICE)

Non-alcoholic fatty liver disease (NAFLD): assessment and management

Click here

 

British Medical Journal

Hepatic steatosis best practice guidelines from the BMJ. Requires journal access.

Click here

Treatment guidelines

Worldwide


World Gastroenterology Organisation

Practice guidelines from the WGO for diagnosis and treatment of NAFLD & NASH

Click here

Regional


American Association for the Study of Liver Diseases (AASLD)

The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases

Click here

 

North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN)

NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children

Click here

 

EASL–EASO–EASD

EASL– European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Click here

Italy


Italian Association for the Study of the Liver (AISF)

Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease

Click here

Spain


Spanish Association for the study of the liver (AEEH)

Consensus document on the management of nonalcoholic fatty liver disease

Click here

United Kingdom


British Medical Journal

Hepatic steatosis best practice guidelines from the BMJ. Requires journal access.

Click here

 

British Society of Gastroenterology

BSG guidelines for liver transplantation for patients with non-alcoholic steatohepatitis

Click here

Information for people with NAFLD/NASH

Worldwide


Global Liver Institute

Curated list of education, support, and tools for patients with liver disease and the people who support them.

Click here

Regional


ELPA (European Liver Patients’ Association)

The Association was formed in 2004 by the amalgamation of 13 patient groups from 10 European and Mediterranean Basin countries

Click here

France


Together Against NASH (Ensemble contre la NASH)

French advocacy group that focuses on preventing through public awareness initiatives, patient support and medical research

Click here

United Kingdom


British Liver Trust

The British Liver Trust provides publications on a range of subjects, including NAFLD, that can be downloaded for free:

Click here

 

Key publications have also been translated for several different nationalities:

Click here

Helpline: 0800 652 7330

Resources for healthcare professionals

Regional


European Association for the Study of the Liver (EASL)

iLiver app is EASL’s own reviewed bedside resource that provides up to date clinical recommendations and information in more than 26 different areas of liver disease.

Click here

 

European Liver Associations

To find a local professional liver association, visit the EASL website

Click here

Calculators and screening tools

International


Alcohol consumption

AUDIT Alcohol Consumption Questions (AUDIT-C)

Click here

 

CAGE Questionnaire for Detecting Alcoholism

Click here

 

Cirrhosis scoring

AST to Platelet Ratio Index (APRI) Calculator

Click here

 

Child-Pugh Score for Cirrhosis Mortality

Click here

 

MELD Score (Model for End-Stage Liver Disease)

Click here

 

Fibrosis score calculators

Enhanced Liver Fibrosis (ELF™) Test offered by Siemens Healthcare

Click here

 

Fibrosis-4 (FIB-4) Calculator

Click here

 

FibroTest offered by Biopredictive

Click here

 

NAFLD fibrosis score calculator

Click here

 

Kidney function

Creatinine Clearance (CrCl) Calculator

Click here

 

eGFR Calculator (The Renal Association)

Click here

United Kingdom


Healthy weight calculators

BMI Healthy Weight Calculator (NHS)

Click here

Continuing medical education

Regional


European Association for the Study of the Liver (EASL)

The EASL LIVERTREETM

EASL members have access to the LiverTree, an online medical educational resource designed by hepatologists for hepatologists.

Click here

 

LiverLearning®

LiverLearning® is the official eLearning portal of AASLD. Users can access educational resources by categories, content type, and events — including videos and slide decks.

Click here

United Kingdom


Royal College of General Practitioners (RCGP)

RCGP Substance Misuse and Associated Health (SMAH) alcohol certificate course.

Click here

 

Clinical Care Options

Medical education materials, conference coverage and opinion pieces dealing with the management of hepatitis, including NASH

Click here

Worldwide


Consideration of the evidence on childhood obesity for the Commission on Ending Childhood Obesity – WHO (mentions NAFLD as a potential consequence)

Click here

NAFLD and NASH

Explore the in-depth content on site related to NAFLD and NASH, covering the burden, identifying people with NAFLD, referral, diagnosis, management and an overview of NASH in the context of diabetes and obesity. 

LID/IHQ/18-12//1048i Date of preparation: MARCH 2019